fepblue glp 1 2025 GLP-1 trends 2025: real-world data, patient outcomes & future therapies In 2025, FEHB enrollees will
Description
Chinese payers are drafting coverage clauses now
Our care team works directly with your insurer to secure approval, so you spend less time on paperwork and more time on your health
and De Man J
The rise comes as more patients turn to these drugs for weight loss, including some who are using compounded or online versions without a prescription
Retrospective study showing residual gastric contents in patients on GLP-1 receptor agonists despite adequate fasting
